Alnylam Pharmace. buy klostergang
Summary
This prediction ended on 17.06.21 with a price of €140.80. With a performance of 96.54% the BUY prediction by klostergang was a big success. klostergang has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
Alnylam Pharmace. | 15.164% | 15.164% | 45.673% | 66.233% |
iShares Core DAX® | -3.935% | -2.628% | 10.013% | 11.951% |
iShares Nasdaq 100 | -3.608% | -9.283% | 20.668% | 35.711% |
iShares Nikkei 225® | -4.513% | -6.951% | 5.241% | 2.602% |
iShares S&P 500 | -2.607% | -4.402% | 20.177% | 37.820% |
Comments by klostergang for this prediction
In the thread Alnylam Pharmace. diskutieren